Literature DB >> 17464755

Dedifferentiation of cells: new approaches.

P Collas1.   

Abstract

Reprogramming of a differentiated cell into a cell capable of giving rise to many different cell types, a pluripotent cell, which in turn could repopulate or repair sick or damaged tissue, would present beneficial applications in regenerative medicine. Somatic cell nuclear transfer may offer this possibility, but technical hurdles and ethical frameworks currently prevent application of this technology in several countries. As a result, alternative strategies to reprogramming cell fate are being developed. This review briefly addresses somatic cell nuclear transfer and focuses on recent non-nuclear transfer-based approaches for reprogramming somatic cells and enhancing their differentiation potential. These include the fusion of somatic cells with embryonic stem cells, the treatment of somatic cells with extract of pluripotent cells and the retroviral transduction of somatic cells to overexpress pluripotency genes.

Mesh:

Year:  2007        PMID: 17464755     DOI: 10.1080/14653240701218532

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  3 in total

1.  Ossabaw Pigs With a PCSK9 Gain-of-Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies.

Authors:  Fang Yuan; Liang Guo; Kyoung-Ha Park; John R Woollard; Kwon Taek-Geun; Kai Jiang; Tamene Melkamu; Bin Zang; Samantha L Smith; Scott C Fahrenkrug; Frank D Kolodgie; Amir Lerman; Renu Virmani; Lilach O Lerman; Daniel F Carlson
Journal:  J Am Heart Assoc       Date:  2018-03-23       Impact factor: 5.501

2.  Dedifferentiation derived cells exhibit phenotypic and functional characteristics of epidermal stem cells.

Authors:  Cuiping Zhang; Xiaobing Fu; Peng Chen; Xiaoxia Bao; Fu Li; Xiaoyan Sun; Yonghong Lei; Sa Cai; Tongzhu Sun; Zhiyong Sheng
Journal:  J Cell Mol Med       Date:  2010-05       Impact factor: 5.310

3.  Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.

Authors:  Sara H Isakson; Anthony E Rizzardi; Alexander W Coutts; Daniel F Carlson; Mark N Kirstein; James Fisher; Jeremie Vitte; Kyle B Williams; G Elizabeth Pluhar; Sonika Dahiya; Brigitte C Widemann; Eva Dombi; Tilat Rizvi; Nancy Ratner; Ludwine Messiaen; Anat O Stemmer-Rachamimov; Scott C Fahrenkrug; David H Gutmann; Marco Giovannini; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Commun Biol       Date:  2018-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.